20899 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tetrapeptides
METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#902Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#903NEURITOGENIC PEPTIDES
#904Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#905COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE
#906ARRY-520 FOR USE IN TREATING CANCER IN A PATIENT WITH LOW AAG
#907Inhibitors of the Epidermal Growth Factor Receptor- Heat Shock Protein 90 Binding Interaction
#908Romidepsin solid forms and uses thereof
#909FLUORINATED EPOXYKETONE-BASED TETRAPEPTIDE COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORS
#910Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#911GALECTIN-3 INHIBITOR (GAL-3M) IS ASSOCIATED WITH ADDITIVE ANTI-MYELOMA AND ANTI-SOLID TUMOR EFFECTS, DECREASED OSTEOCLASTOGENESIS AND ORGAN PROTECTION WHEN USED IN COMBINATION WITH PROTEASOME INHIBITORS
#912METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS
#913Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#914CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION
#915Liposomal compositions of epoxyketone-based proteasome inhibitors
#916LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS
#917Derivatives of pyridinone as inhibitors for tissue transglutaminase
#918Low frequency glatiramer acetate therapy
#919Synthetic peptide amides
#920Methods for Treating HCV
#921Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#922Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#923Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#924RFamide-related peptides and methods thereof
#925Methods of Treating Depression and Other Related Diseases
#926HCV protease inhibitors and uses thereof
#927Compositions And Methods For Modulating Pro-Inflammatory Immune Response
#928Peptoids useful for the mineralization of apatite
#929METHODS FOR TREATING LIVER TRANSPLANT RECIPIENTS
#930Linear peptide antibiotics
#931LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#932Methods for Treating HCV
#933Systems for treating an opioid-induced adverse pharmacodynamic response
#934Methods for treatment of atherosclerosis
#935Uses of kappa opioid synthetic peptide amides
#936COMPOSITIONS AND METHODS FOR TREATMENT
#937Methods and compositions for treating pain
#938PERIPHERAL KAPPA RECEPTOR AGONISTS FOR REDUCING PAIN AND INFLAMMATION
#939Drug-conjugates, conjugation methods, and uses thereof
#940Antiviral compounds
#941Peptide-oligourea chimeric compounds and methods of their use
#942COMPOSITIONS AND METHODS FOR TREATMENT
#943COMPOSITIONS AND METHODS FOR TREATMENT
#944COMPOSITIONS AND METHODS FOR TREATMENT
#945COMPOSITIONS AND METHODS FOR TREATMENT
#946COMPOSITIONS AND METHODS FOR TREATMENT
#947COMPOSITIONS AND METHODS FOR TREATMENT
#948Compositions and methods for promoting wound healing and tissue regeneration
#949Sleep apnea treatment
#950Compositions and methods for increasing carnitine level in muscle tissue
#951Glutathione-elevating compositions and uses thereof
#952Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
#953Tubulysin compounds, methods of making and use
#954Oral delivery of peptide pharmaceutical compositions
#955Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#956MODULATION OF ANGIOTENSIN II RECEPTORS FOR THE PREVENTION AND TREATMENT OF MALARIA CEREBRAL
#957AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#958Cyclodextrin complexation methods for formulating peptide proteasome inhibitors
#959Drug-conjugates, conjugation methods, and uses thereof
#960Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#961Nutritional composition containing a peptide component with anti-inflammatory properties and uses thereof
#962Peptides for management of lactation
#963Methods and compositions for the prevention and treatment neuropathy
#964REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#965Cholecystokinin B receptor targeting for imaging and therapy
#966Alkylated cyclodextrin compositions and processes for preparing and using the same
#967Antiviral methods and compositions comprising probiotic bacterial molecules
#968Compositions and methods for the treatment of retinal degeneration
#969Peptide pharmaceuticals
#970Macrocyclic compounds for suppressing replication of hepatitis C virus
#971Benzodiazepine derivatives
#972Solid compositions
#973Methods for Treating HCV
#974Methods for treating HCV
#975Modulation of activity of proneurotrophins
#976Combinations of albumin-based drug delivery systems
#977Eye drops
#978Cosmetic use of an albizia julibrissin extract and corresponding topical composition
#979Site-specific chemoenzymatic protein modifications
#980Combinations and uses thereof
#981Cyclin based inhibitors of CDK2 and CDK4
#982Methods for Treating HCV
#983Aromatic-cationic peptides and uses of same
#984Combination therapy with peptide epoxyketones
#985Combination therapies using cyclosporine and aromatic cationic peptides
#986Cytotoxic peptides and antibody drug conjugates thereof
#987Neurotrophic peptides for the treatment of tauopathies
#988Organic compounds and their uses
#989Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#990Methods for reducing oxidative damage
#991Self-assembled composite ultrasmall peptide-polymer hydrogels
#992HCV NS3 protease inhibitors
#993Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#994COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#995ROMIDEPSIN SOLID FORMS AND USES THEREOF
#996METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#997Methods for Treating HCV
#998METHOD OF REDUCING AND IMPROVING THE APPEARANCE OF SCAR TISSUE
#999Self-assembling peptides incorporating modifications and methods of use thereof
#1000Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#1001Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#1002HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
#1003Peptides for skin rejuvenation and methods of using the same
#1004Methods and compositions for treating pain
#1005Compositions and methods for the treatment of cardiac surgery-associated acute kidney injury with annexin A1 peptide
#1006NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#1007Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#1008PEPTIDOMIMETIC PROTEASE INHIBITORS
#1009Methods for the prevention and treatment of burn injuries and secondary complications
#1010Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
#1011Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
#1012Nutritional compositions containing a peptide component and uses thereof
#1013IFNγR2 compositions and methods of inhibiting neuronal cell death
#1014FAP-activated proteasome inhibitors for treating solid tumors
#1015METHODS OF TREATING NEUROPATHIC PAIN
#1016Galectin-3C combination therapy for human cancer
#1017Aromatic-cationic peptides and methods for using same
#1018Tubulysin compounds, methods of making and use
#1019Method For Elevating Prolactin In Mammals
#1020TRANSFORMATION OF DRUG CYCLODEXTRIN COMPLEX COMPOSITIONS INTO COMPOSITIONS OF MIXTURES OF LIPID VESICLE ENCAPSULATED DRUG AND CYCLODEXTRIN DRUG COMPLEXES
#1021REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
#1022REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
#1023Use of plant cell membrane treatment of obesity
#1024Use of plant cell membrane treatment of obesity
#1025COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#1026Methods for treating brain injury
#1027Role of ADAM10 and its relevance to disease and therapeutics
#1028Compositions and methods for treatment
#1029Compound and method for modulating opioid receptor activity
#1030Method of treatment or prophylaxis of inflammatory pain
#1031Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue
#1032Macrocyclic broad spectrum antibiotics
#1033Compounds and Methods for Appetite Suppression and Weight Control
#1034TREATMENT OF HEPATITIS C VIRUS WITH TELAPREVIR (VX-950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFERON-ALPHA 2A/2B AND RIBAVIRIN
#1035HCV Combination Therapy
#1036Repairing Bruch's membrane with hydrogels
#1037Peptide analogues with an excellent moisturizing effect and use thereof
#1038METHODS OF TREATING ALZHEIMER'S DISEASE, HUNTINGTON'S DISEASE, AUTISM, OR OTHER DISORDERS
#1039Methods for prevention and treatment of acute renal injury
#1040Methods for treating HCV
#1041METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#1042Amphiphilic linear peptidepeptoid and hydrogel comprising the same
#1043sGCalphal inhibiting compositions
#1044Hepatocyte growth factor mimics as therapeutic agents
#1045Anti-microbial peptides and uses of same
#1046PGC-1α-modulating peptides
#1047Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#1048N-carboxyalkylauristatins and use thereof
#1049Stable compositions of peptide epoxy ketones
#1050COMBINATIONS OF HDAC INHIBITORS AND PROTEASOME INHIBITORS
#1051SMAC mimetic for treating myelodysplastic syndromes
#1052GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING
#1053Tight junction protein modulators and uses thereof
#1054METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#1055Nanoparticles containing pH-responsive peptide
#1056Methods and compositions for preventing or treating ophthalmic conditions
#1057INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
#1058Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
#1059HYDROGEL COMPOSITIONS
#1060Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple sclerosis
#1061Methods and compositions for the treatment of axonal and neuronal degeneration
#1062HCV protease inhibitors and uses thereof
#1063Aminostatin derivatives for the treatment of arthrosis
#1064Methods of treating depression and other related diseases
#1065Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#1066Methods of treating depression and other related diseases
#1067Method for treating disorders of the skin
#1068Benzodiazepine derivatives
#1069Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
#1070Methods of Treating Depression and Other Related Diseases
#1071Antibody formulations and methods
#1072Methods of treating depression and other related diseases
#1073POLYCYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
#1074Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#1075Pharmaceutical Compositions
#1076Treatment of penetrative injury to the brain
#1077Benzodiazepine derivatives
#1078N-carboxyalkyl-auristatin and the use thereof
#1079Peptide compound useful for inhibiting amyloid plaque formation
#1080Methods for preventing or treating mitochondrial permeability transition
#1081Immunostimulatory method
#1082CELLULAR BLOOD MARKERS FOR EARLY DIAGNOSIS OF ALS AND FOR ALS PROGRESSION
#1083Linear peptide antibiotics
#1084Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#1085Glutathione-Lanthionine Compounds and Methods Related Thereto
#1086Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury
#1087Detection and treatment of autoimmune disorders
#1088METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#1089METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#1090Vitamin E formulations of sulfamide NS3 inhibitors
#1091HCV NS3 PROTEASE INHIBITORS
#1092METHODS FOR TREATING HCV
#1093SOLID COMPOSITIONS
#1094Hepatocyte growth factor mimics as therapeutic agents
#1095Low frequency glatiramer acetate therapy
#1096Polypeptides for the treatment or prevention of cancer and uses thereof
#1097ORGANIC COMPOUNDS AND THEIR USES
#1098Peptides for promoting angiogenesis and use thereof
#1099Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#1100METHODS FOR INHIBITING NECROSIS
#1101Cosmetic composition containing oligopeptides
#1102Methods for treating HCV
#1103Methods for treating HCV
#1104Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
#1105Methods for treating HCV
#1106Methods for treating HCV
#1107Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis
#1108Methods for Treating HCV
#1109Combination therapies using cyclosporine and aromatic cationic peptides
#1110NMDA receptors modulators and uses thereof
#1111Peptidomimetic sulfamide compounds and antiviral uses thereof
#1112Peptidomimetic sulfamide compounds and antiviral uses thereof
#1113Methods for prevention and treatment of acute renal injury
#1114SMAC mimetic
#1115Synthetic peptide amides for pain
#1116Method For Elevating Prolactin In Mammals
#1117Artificial skin
#1118Methods of treating depression and other related diseases
#1119Proteinase K inhibitors, methods and compositions therefor
#1120Oral delivery of peptide pharmaceutical compositions
#1121Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#1122Hemiasterlin derivatives and uses thereof in the treatment of cancer
#1123Neuronal pain pathway
#1124Methods of treating depression and other related diseases
#1125COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NECROSIS
#1126Peptidomimetic protease inhibitors
#1127Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
#1128Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide
#1129Uses of hypoxia-inducible factor inhibitors
#1130COMPOSITIONS AND METHODS FOR INHIBITING AND/OR MODULATING EFFECTOR T-CELLS INVOLVED IN INFLAMMATORY NEURODEGENERATIVE DISEASE
#1131ADMINISTERING ANTI-PLACENTAL GROWTH FACTOR ANTIBODIES
#1132Tubulin inhibitors
#1133NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#1134Compositions and methods for treatment of eye disorders
#1135Organic compounds and their uses
#1136THERAPEUTIC AGENT FOR GASTROINTESTINAL DISEASE
#1137Method and compositions for treating stroke with fever
#1138ROMIDEPSIN SOLID FORMS AND USES THEREOF
#1139Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
#1140HCV protease inhibitors and uses thereof
#1141METHODS OF TREATING NEUROPATHIC PAIN
#1142Eye drops
#1143METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#1144Anti-Gram Negative Bacteria Agent
#1145DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#1146Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#1147SMAC MIMETEC
#1148COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#1149Method of treating tumors
#1150Beta-glucuronide-linker drug conjugates
#1151Proteasome-activating lightening peptidic hydrolyzates and compositions containing them
#1152Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#1153Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate
#1154Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function
#1155Peptide fragments for inducing synthesis of extracellular matrix proteins
#1156Topical Anesthetic Uses of Szeto-Schiller Peptides
#1157Composition for improving brain function and method for improving brain function
#1158Treatment for anxiety
#1159Low frequency glatiramer acetate therapy
#1160Peptidomimetic protease inhibitors
#1161Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
#1162Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
#1163ROMIDEPSIN SOLID FORMS AND USES THEREOF
#1164Antagonists of MUC1
#1165Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin
#1166Cyclic peptides with an anti-parasitic activity
#1167Methods for preventing or treating mitochondrial permeability transition
#1168Self-assembling peptides incorporating modifications and methods of use thereof
#1169COMBINATION THERAPIES WITH COX-2 INHIBITORS AND TREPROSTINIL
#1170Soothing pharmaceutical or cosmetic composition comprising a peptide that activates HMG-CoA reductase
#1171Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
#1172Use of lumefantrine and related compounds in the treatment of cancer
#1173Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#1174MATERIALS AND METHODS FOR TREATMENT OF INFLAMMATION
#1175Inhibition of gliadin peptides
#1176Tight junction protein modulators and uses thereof
#1177PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#1178Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
#1179Topical Uses of Szeto-Schiller Peptides
#1180TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION
#1181Treatment of biofilms
#1182COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES
#1183Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950 for the Treatment of Hepatitis
#1184Treatment of diseases and conditions mediated by increased phosphorylation
#1185Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#1186Treatment of dissection, aneurysm, and atherosclerosis using granzyme B inhibitors
#1187Uses of kappa opioid synthetic peptide amides
#1188Use of plant cell membrane for the treatment of obesity
#1189Compositions containing interleukin-1 and peptides
#1190Peptide compositions and therapeutic uses thereof
#1191Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction
#1192Compositions and methods for the diagnosis and treatment of tumor
#1193Methods and compositions for preventing or treating ophthalmic conditions
#1194Anti-hypertensive agent
#1195Compositions and methods for treatment
#1196Compositions and methods for treatment
#1197MODULATION OF CASPASES AND THERAPEUTICAL APPLICATIONS
#1198TIGHT JUNCTION PROTEIN MODULATORS AND USES THEREOF
#1199Methods and compositions for preventing adhesion
#1200Method of inhibiting platelet aggregation and clot formation